Erytech Pharma S.A.

Company Listings from SPi: Erytech Pharma S.A.

You are here: Home >> SPi Company Listings >> Erytech Pharma S.A.

 

Erytech Pharma S.A.

Website:
http://

Search for other references to "erytech" on SPi News

Latest Erytech Pharma S.A. News

ERYTECH Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- The TRYbeCa1 (NCT03665441) trial will enroll approximately 500 patients with second line metastatic pancreat...... 06:30 GMT Thursday 20th September 2018

ERYTECH to Attend Upcoming Investor Conferences LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company developing innovative therapies for rare...... 06:30 GMT Thursday 13th September 2018

ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update Conference call and webcast scheduled for Tuesday, September 11at 2:30 pm CET/8:30 am EDTLYON , France and CAMBRIDGE, Mass., Sept. 10, 2018 (GLOBE NEWSWIRE) -- As a reminder, ER...... 21:30 GMT Monday 10th September 2018

ERYTECH to Host Second Quarter 2018 Conference Call and Business Update LYON, France, Sept. 06, 2018 (GLOBE NEWSWIRE) -- The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: :The webcast can be followed live...... 06:30 GMT Thursday 6th September 2018

ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018 LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon...... 21:30 GMT Tuesday 17th July 2018

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT Focuses development efforts on solid tumor indications Confirms planned launch of company-sponsored random...... 23:06 GMT Sunday 24th June 2018

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia LYON, France and CAMBRIDGE Mass., June 24, 2018 (GLOBE NEWSWIRE) -- (Euronext:ERYP) (Nasdaq:ERYP) In 2017, ERYTECH announced positive results from a Phase 2b clinical trial of er...... 21:51 GMT Sunday 24th June 2018

ERYTECH to Present at JMP Securities Life Science Conference LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative thera...... 06:30 GMT Wednesday 20th June 2018

ERYTECH to Present at JMP Securities Life Science Conference LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- (Euronext Paris:ERYP) (Nasdaq:ERYP)Founded in Lyon, France in 2004, ERYTECH is a clinical-stage biopharmaceutical company develo...... 06:30 GMT Wednesday 20th June 2018

ERYTECH to Present Preclinical and Clinical Data on Use of Eryaspase in ALL and AML at EHA 2018 LYON, France, June 15, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies b...... 06:31 GMT Friday 15th June 2018

Buy Erytech Pharma S.A.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us